Castera L
-
An Invisible Early Steatosis Phenotype Defined for a Large Population-Based Cohort.
-
Noninvasive Assessment of Liver Fibrosis. Key publication Review
-
Prospective direct comparison of non-invasive liver tests in outpatients with type 2 diabetes using intention-to-diagnose analysis. Key publication
-
Prospective external validation of a new non-invasive test for the diagnosis of non-alcoholic steatohepatitis in patients with type 2 diabetes. Key publication
-
Performance of liver biomarkers, in patients at risk of nonalcoholic steato-hepatitis, according to presence of type-2 diabetes. Key publication
-
Screening studies of transient elastography and FibroTest in the general population - Authors' reply.
-
Noninvasive Assessment of Liver Fibrosis.
-
Comparison of transient elastography (FibroScan), FibroTest, APRI and two algorithms combining these non-invasive tests for liver fibrosis staging in HIV/HCV coinfected patients: ANRS CO13 HEPAVIH and FIBROSTIC collaboration.
-
Hepatitis B: are non-invasive markers of liver fibrosis reliable? Review
-
Noninvasive evaluation of NAFLD. Review
-
The new paradigm of hepatitis C therapy: integration of oral therapies into best practices. Review
-
Comparison of three algorithms of non-invasive markers of fibrosis in chronic hepatitis C.
-
The impact of liver disease aetiology and the stages of hepatic fibrosis on the performance of non-invasive fibrosis biomarkers: an international study of 2411 cases.
-
ActiTest accuracy for the assessment of histological activity grades in patients with chronic hepatitis C, an overview using Obuchowski measure. Meta Analysis
-
Non-invasive assessment of liver fibrosis: are we ready?
-
SAFE biopsy: a validated method for large-scale staging of liver fibrosis in chronic hepatitis C.
-
Transient elastography and other noninvasive tests to assess hepatic fibrosis in patients with viral hepatitis. Review
-
Evolving practices of non-invasive markers of liver fibrosis in patients with chronic hepatitis C in France: time for new guidelines?
-
Meta-analyses of FibroTest diagnostic value in chronic liver disease. Key publication Meta Analysis
-
Standardization of ROC curve areas for diagnostic evaluation of liver fibrosis markers based on prevalences of fibrosis stages. Key publication
-
Variability of the area under the receiver operating characteristic curves in the diagnostic evaluation of liver fibrosis markers: impact of biopsy length and fragmentation.
-
FibroScan and FibroTest to assess liver fibrosis in HCV with normal aminotransferases.